The lesions were present for 7 months ... Etiology: Lichen planus is a common, pruritic, inflammatory disease of the skin, hair follicles, and mucous membranes. The cause of lichen planus is ...

A 62-year-old woman with a history of hypercholesterolemia consulted for intensely pruritic skin lesions that developed over the last month on her extremities and trunk. Additional history of new ...

Skin (cutaneous) lymphomas often manifest as a skin rash. Although usually identified early, skin lymphomas can be mistaken for other skin conditions, delaying diagnosis. Non-Hodgkin's lymphoma (NHL) ...

Xerosis is the most common cause of pruritus without an accompanying rash, and it can be associated with inflammatory skin diseases including atopic dermatitis, systemic diseases such as ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

In patients with cancer, HT-001, designed to address skin toxicities, elicited encouraging interim safety and efficacy ...

21, 2024 — Hidradenitis suppurativa (HS) is an immune disease that affects up to 4% of the global population and causes painful, recurring skin lesions and ... Scientists Develop Breakthrough ...

Molluscum contagiosum is a skin infection caused by a virus of the same name. It produces benign, raised bumps, or lesions, on the upper layers of your skin. The small bumps are usually painless.

Liver disease can be fatal and is often referred to as a silent killer because it can have no symptoms until it is too late.

“One of the first side effects of declining liver function is that bile flow stalls in your biliary tract. Your liver no longer produces or delivers bile effectively to your small intestine. Instead, ...

Miliaria rubra is a type of heat rash or prickly heat that happens when sweat becomes trapped under the skin. Children tend to get it more than adults because their sweat glands are still developing.

Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.